Connect with us
  • Elysium

Brain injury news

Chroma announces new partnership with Isofi

Published

on

Chroma, the provider of creative arts therapies, has partnered with Isofi to help revolutionise GenZ and millennials mental health at work through music.

Isofi is an AI-driven platform and service that assists music therapists to deliver music therapy sessions to employees in a range of businesses to support their mental wellbeing, whilst supporting businesses’ existing Employee Assistance Programs (EAPs).

Isofi’s technology utilises clients’ music playlists to quickly develop personalised, music playlist-based coping strategies for anxiety and common stresses.

The partnership is currently delivering a series of pilots with businesses for their employees that are focused on prevention and early intervention for mental health – providing coping strategies for common stressors.

The platform is fully Health and Care Professions Council compliant and can be used in both remote and in-person sessions.

Daniel Thomas, managing director at Chroma said: “Isofi really is revolutionising the way in which we are able to support mental health in the workplace, and we are delighted to be a part of this, providing support to so many – all over the world.

“The accessible approach to music therapy is an ideal way to reach people in a non-clinical, personable style and we look forward to delivering this service to businesses to help support mental health in the workplace.”

Russell Newell, Founder and CEO of Isofi added: “I was motivated to develop the platform in response to mental health issues faced by adolescent family members who were using music as a way to cope with challenging situations – effective and positive in many ways but could sometimes lead to rumination and dwelling on negative experiences.

“With Isofi, people can now use their own music tastes and choices to ‘effectively’ improve their mental state.”

“We have spent 5 years developing a relationship with the music therapy community in the UK and US to develop and validate our platform ensuring Isofi works with music therapists to deliver a service to business using our technology, and we’re delighted Chroma’s music therapists have joined the team.

“Chroma’s highly qualified, reputable music therapists ensure this platform benefits those who need it, and with their support, Isofi can realise our vision of creating intentional, personalised playlists based on people’s preferred music using artists’ current output in streaming services.”

The Chartered Institute of Personnel and Development (CIPD) states mental health issues affect at least 1 in 4 people at work and is a leading cause of long-term absence.

Employers who support the mental wellbeing of staff benefit from greater staff productivity, higher levels of morale and retention, reduced sickness absence and ‘presenteeism’.

Russell continued, “The WHO commissioned a study in 2016 that estimated a $4 return for every $1 spent on mental health.

“Many big companies already have Employee Assistance Programs (EAP) in place but experience as little as 4-8 per cent engagement levels.

“Isofi aims to change this as it’s a high engagement service that complements a business’s existing EAP making it an ideal way for employers to promote and support mental health within the workplace.”

“We know from experience that younger people find it hard to reach for therapy assistance, but they often turn to music to improve mood.

“We also, know music can be an effective approach to improve mental wellbeing. This is why, Currently, Isofi is focussed on engaging Gen Z and Millennials in the workplace.”

Erin Seibert, Isofi’s Communications & Therapist Liaison Director added, “Isofi is a tool that was built to empower music therapists to use music technology more accurately and efficiently within their therapy practice.

“It was created to be adapted to any population as assessed as appropriate by the therapist and we are excited to have Chroma therapists help us to realise this within their practice.

“We are currently piloting its use with more generalised, neurotypical individuals with a focus on preventative care.

“This will allow us to ensure its efficacy when working with other populations, including ABI, as part of our future goals.”

HIWIN

Trending